CFRA analyst Wan Nurhayati revised the price target for GlaxoSmithKline (NYSE:GSK) shares, reducing it to $40.00 from the ...
Just recently, an institution picked up $1.33 million worth of the AMZN March 21, 2025 calls. Another picked up $1.31 million ...